HETERO DRUGS LIMITED UNIT I.

Business Type: Manufacturer (Factory)

Company Overview:

Hetero Drugs Limited Unit I is a prominent manufacturing facility operated by Hetero, one of India's leading generic pharmaceutical companies. This unit is primarily engaged in the large-scale production of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The facility adheres to stringent international regulatory standards, including approvals from global health authorities such as the USFDA. It specializes in the synthesis of complex chemical compounds and the mass production of essential medications, particularly in the therapeutic areas of anti-retrovirals, oncology, cardiovascular health, and neurology. As a key manufacturing site, the unit focuses on research-driven production, quality control, and the efficient supply of high-quality pharmaceutical products to both domestic and international markets.

Hetero Drugs Limited Unit I manufactures and sells a wide range of pharmaceutical products, primarily focusing on Active Pharmaceutical Ingredients (APIs) and finished dosages. Their key product categories include:

Antiretrovirals: Medicines for the treatment of HIV/AIDS.

Hepatitis Medications: Treatments for Hepatitis B and C.

Oncology Drugs: Medications for cancer therapy.

Cardiovascular Medicines: Drugs for heart and blood vessel conditions.

Neurology Products: Treatments for neurological disorders.

Gastroenterology Drugs: Medications for digestive system health.

Anti-infectives: Antibiotics and antiviral agents.

Immunology Products: Treatments for immune system-related conditions.

The facility focuses on the large-scale production of high-quality chemical intermediates and bulk drugs that are exported globally to support various therapeutic segments.